iBrands Corp. (IBRC)

[centsability4me]

IBRC DD

iBrands Corporation is a holding and branding company that acquires and operates niche market brands that have unique market positions within sectors that demonstrate return on investment potential. Business partnerships throughout the United States, Canada, Mexico, South America, and Europe provide our brands many markets to expand into and produce consistently high growth rates for the next decade.

NEWS 6/29/20
iBrands Corporation Reports Reduction of Brain Inflammation/Depression Associated Biochemical Pathway Using QuadraMune™ in Animal Studies

http://www.globenewswire.com/news-release/2020/06/29/2054767/0/en/iBrands-Corporation-Reports-Reduction-of-Brain-Inflammation-Depression-Associated-Biochemical-Pathway-Using-QuadraMune-in-Animal-Studies.html

LAS VEGAS, June 29, 2020 (GLOBE NEWSWIRE) -- iBrands Corporation (OTC: IBRC) (“the Company”), a diversified holding and branding company, announces filing of a new patent by nutraceutical product manufacturer Therapeutic Solutions Int’l (TSOI) covering suppression of the indolamine 2,3 deoxygenase (IDO) pathway by QuadraMune™ administration.

In the study, mice were administered lipopolysaccharide (LPS), a compound known to stimulate inflammation, in order to replicate inflammation-associated depression. Mice receiving LPS suffered a reduction in memory activity, as quantified using the Morris Water Maze test.

Administration of QuadraMune™ significantly inhibited inflammation associated with memory impairment, as well as reduced levels of kynurenine. Elevation of kynurenine is associated with activation of indolamine 2,3 deoxygenase, an enzyme associated with inflammation and depression [1].

"The current data support the possibility of QuadraMune™ being used as an adjuvant to numerous immune therapies whose efficacy is currently inhibited by the depression-inducing and immune blocking effects of the indolamine 2,3 deoxygenase enzyme," said Dr. James Veltmeyer, Chief Medical Officer and co-inventor of the current patent. "Many times, when you activate the immune system, cells in the body, and in the brain, start producing the enzyme indolamine 2,3 deoxygenase, whose role is to restrain the immune system, and for reasons unknown, causes depression. By manipulating this enzyme through natural means, we are optimistic that we can enhance the efficacy of numerous immune modulatory treatments for viral and neoplastic conditions."

Dr. Thomas Ichim, Board Member of Therapeutic Solutions International, has been working on this enzyme since 2013 when he published in the peer-reviewed literature regression of breast cancer using RNA interference to block its expression [2].

"From a commercialization perspective we are truly optimistic about the implications of the current results, which may require us to consider expanding our clinical trial programs," said Timothy Dixon, President, and CEO of the Company. "The IDO enzymatic pathway is not only extremely interesting from a medical perspective, but companies working on manipulating this pathway have previously entered Big Pharma deals with potential values in excess of $1 billion [3]. In contrast to other programs that utilize synthetic approaches, QuadraMune™, which is comprised of natural ingredients and is available as a nutraceutical, may possess numerous advantages for accelerated commercialization."

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

About iBrands Farms

iBrands Farms is a vertically integrated agribusiness focused on the production of hemp derived products with naturally occurring cannabinoids along with other nutraceutical products. Our mission is to efficiently deliver the highest quality products to our customers, both retail and B2B.

The company can be found at www.ibrandsfarms.com

NEWS 6/17/2020
iBrands Corporation Announces Clinical Trial For Immune Booster Product

https://www.otcmarkets.com/stock/IBRC/news/iBrands-Corporation-Announces-Clinical-Trial-For-Immune-Booster-Product?id=265070

LAS VEGAS, June 17, 2020 (GLOBE NEWSWIRE) -- iBrands Corporation (OTC: IBRC) (“the Company”), a diversified holding and branding company, announces clinical trial for Quadramune™, the Company’s featured immune boosting nutraceutical product on it’s online store.

The Company's nutraceutical manufacturer, Therapeutics Solutions International, Inc. (TSOI), announced the initiation of a clinical trial aimed at demonstrating safety and efficacy of its immune-boosting formulation QuadraMune™. Last week the TSOI announced data from a preliminary clinical trial in which four groups of eight volunteers were treated with placebo or escalating doses of QuadraMune™[1]. Elevation of innate immune response activity was observed, together with a decreased responsiveness towards inflammatory stimuli.

These preliminary data were analyzed by the TSOI's Scientific Advisory Board, who then recommended proceeding to the larger trial. The trial will recruit 500 subjects at risk of SARS-CoV-2 infection, the type of coronavirus which causes COVID-19.

The new clinical trial has been granted ClinicalTrials.gov Identifier: NCT04421391 and is now on the Federal Clinical Trial registry: https://www.clinicaltrials.gov/ct2/show/NCT04421391

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

About iBrands Farms

iBrands Farms is a vertically integrated agribusiness focused on the production of hemp derived products with naturally occurring cannabinoids along with other nutraceutical products. Our mission is to efficiently deliver the highest quality products to our customers, both retail and B2B.

The company can be found at www.ibrandsfarms.com

About iBrands Corporation

iBrands Corporation, Inc. is a holding and branding company that acquires and operates niche market brands that have unique market positions within sectors that demonstrate return on investment potential. Business partnerships throughout the United States and Canada provide our brands many markets to expand into and produce consistently high growth rates for the next decade.

The company can be found at: www.ibrandscorporation.com

Sources:

[1] https://www.clinicaltrials.gov/ct2/show/NCT04421391

For more information please contact:

[e-mail]

NEWS 4/27/2020
iBrands Corporation Adds Immune Booster To Nutraceutical Product Line
https://www.otcmarkets.com/stock/IBRC/news/iBrands-Corporation-Adds-Immune-Booster-To-Nutraceutical-Product-Line?id=260192

NEWS 3/23/20
iBrands Corporation Enters Into Distribution Agreement With Medical Supply Group
https://www.globenewswire.com/news-release/2020/03/23/2004791/0/en/iBrands-Corporation-Enters-Into-Distribution-Agreement-With-Medical-Supply-Group.html

NEWS 2/12/20
IBrands Corporation Enhances Net stockholder Equity
https://www.globenewswire.com/news-release/2020/02/12/1983852/0/en/iBrands-Corporation-Enhances-Net-Stockholder-Equity.html

NEWS 1/27/20
iBrands Corporation Address To Shareholders
Las Vegas, Nevada - iBrands Corporation (OTC: IBRC) (“the Company”), a diversified holding and branding company, announces its letter to shareholders.
https://backend.otcmarkets.com/otcapi/company/dns/news/document/40083/content

NEWS 1/21/20
Therapeutic Solutions International Enters into Multi-Million Dollar Master Sales Agreement with Publicly Traded iBrands Corporation
Proprietary Nano Particle Cannabidiol based products to be sold through iBrands Farms
https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/81567715/therapeutic-solutions-international-enters-into-mu
TSOI Products in IBRC Sales Agreement :
NanoStilbene PKE http://mynanostilbene.com/
Nano PSA https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/80285424/therapeutic-solutions-international-develops-gluco?_ga=2.179046118.372974125.1561310240-1993038973.1559041875
NanoPlus http://www.youcanordernow.com/NanoPlus-12ml-wgraduated-glass-eyedropper_p_29.html
Nano Cannabidiol http://www.youcanordernow.com/Nano-Cannabidiol-12ml-w-glass-eyedropper_p_30.html
Projuvenol http://projuvenol.com/
TSOI website :
https://therapeuticsolutionsint.com/

SHARE STRUCTURE
https://www.otcmarkets.com/stock/IBRC/security

AS
994,999,999,999
7/16/20
OS
20,248,527,624
7/16/20
Restricted
17,403,827,580
7/16/20
Unrestricted
2,844,700,044
7/16/20
Float
2,151,000,044
11/22/19

Transfer Agent
Clear Trust, LLC
16540 Point Village Dr. Suite 206
Lutz, FL 33558
Tel: [phone]

Corporate Website :
http://www.ibrandscorporation.com/

IBRC Twitter :
https://twitter.com/search?q=%24IBRC&src=typd
https://twitter.com/otcibrc


iBrands Farms / E - Commerce Site :
https://www.ibrandsfarms.com/

iBrands Farms is a vertically integrated agribusiness focused on the production of hemp derived products with naturally occurring cannabinoids. Our mission is to efficiently deliver the highest quality industrial hemp-derived cannabinoid products to our customers, both retail and B2B.

BudCube Cultivation Systems :
http://www.budcube.com/

BudCube Cultivation Systems offer a fully-portable and scalable, cultivation technology that serves as outdoor turn-key solution for cultivators of legal medical and recreational cannabis, as well as other various plant species. The real estate development and property management business model can be duplicated anywhere in the world where the cultivation of cannabis is legal.

Disclaimer : Please Do Your Own DD when making your trading decisions . All of the information presented in the IBOX , Stickies , or anyone's posts on this board , is based on an individual opinion, and is not to be considered as a recommendation to buy , sell , or hold this stock , or any stock. Information can also become outdated . When doing DD it's always important to check , and verify info from several different places. Never base your trading decisions , on one source , and Do Your own DD first.